Skip to content

Anesthesiology Intensive Care Unit (IT2) ECMO Registry - Phase I

Anesthesiology Intensive Care Unit (IT2) ECMO Registry - Phase I

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00035277
Enrollment
800
Registered
2024-10-16
Start date
2024-10-22
Completion date
Unknown
Last updated
2025-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

OPS 8-852

Interventions

Group 1: Retrospective data evaluation and population register information to determine long-term survival. ECMO therapies on IT2 between 2013 and 2023.

Sponsors

Universitätsklinikum Essen - Klinik für Anästhesiologie und Intensivmedizin
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: ECMO therapy in the anesthesiological intensive care unit

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

MeasureTime frame
Long-term survival via Melderegisterauskunft §44 and §45 BMG

Secondary

MeasureTime frame
Characterization of the patients: Old Gender Pre-existing conditions Premedication nicotine Anamnesis If discharged (for registration information and determination of survival or date of death and contact in the event of long-term survival) name birth date Last known address Description of the treatment course: Duration of stay Ventilation Organ replacement procedures Surgical interventions laboratory Microbiology/Virology Imaging Outcome Survive ECMO therapy Discharge from intensive care unit Hospital discharge If dismissed: via registration information

Countries

Germany

Contacts

Public ContactJan Wiefhoff

Universitätsklinikum Essen - Klinik für Anästhesiologie und Intensivmedizin

jan.wiefhoff@uk-essen.de+49 0201 723 1401

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026